We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Global Blood Collection Devices Market to Reach USD 7.8 Billion by 2026 Due to Increasing Incidence of Infectious Diseases

By LabMedica International staff writers
Posted on 14 Mar 2022
Print article
Image: Global blood collection devices market is projected to reach USD 7.8 billion by 2026 (Photo courtesy of Pexels)
Image: Global blood collection devices market is projected to reach USD 7.8 billion by 2026 (Photo courtesy of Pexels)

The global blood collection devices market is projected to register a CAGR of 6.0% from USD 5.7 billion in 2021 to USD 7.8 billion by 2026, driven primarily by the increasing incidence of infectious diseases, rising number of accidents & trauma cases, emergence of liquid biopsy tests, and demand for blood donations and blood components. However, the complexities of storage and shipping, and lack of skilled professionals are expected to restrain market growth during the forecast period.

These are the latest findings of Research and Markets (Dublin, Ireland), a market research store.

Based on method, the automated blood collection segment is projected to register a higher CAGR during the forecast period due to the increasing demand for safer procedures and availability of advanced blood collecting products. However, manual blood collection is the most widely used method in the blood collection devices market and is expected to account for the largest share in 2021.

Based on end-user, hospitals, ASCs and nursing homes segment is estimated to account for the largest share of the blood collection devices market in 2021. The increasing incidence of infectious diseases and rise in the number of trauma cases, as well as C-sections and organ transplants, is ensuring demand for blood collection equipment and devices in hospital facilities and expanded capabilities, thereby driving market growth.

Geographically, North America (comprising the US and Canada) is expected to account for the largest share of the global blood collection devices market in 2021, followed by Europe. Factors such as increasing prevalence of lifestyle diseases and rising incidence of blood disorders, better healthcare facilities, and the presence of major manufacturers in the region are stimulating the growth of the blood collection devices market in North America. However, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period.

Related Links:
Research and Markets 

Gold Supplier
Proficiency Assessment Software
CellaVision Proficiency Software
New
Automatic Hematology Analyzer
BF-7200Plus
New
Automated R-AST Solution
Radian BC
New
3-Part Diff Hematology Analyzer
DLB3

Print article

Channels

Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons)

Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis

A recent study added weight to the theory that methylated DNA biomarkers could be used for cancer diagnosis and prognosis. Methylation is a biological process by which methyl groups are added to a DNA molecule.... Read more

Hematology

view channel
Image: Standard test for multiple myeloma provides clues of a rare, more deadly type (Photo courtesy of Pexels)

Standard Blood Cancer Test Provides Clues of Rare IgD Multiple Myeloma

IgD myeloma accounts for about 1% of common blood cancer multiple myeloma and has a worse prognosis. Specific testing for IgD myeloma is available at a handful of reference labs across the US, but takes... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.